This website is for healthcare professionals and other relevant decision makers only.
Unlocking the Value: Quantifying the ROI of Hospital AI
Healthcare providers prefer technologies with evidence of a strong bottom-line impact and a tangible near-term return on investment (ROI).
So far, there is limited evidence assessing how AI solutions affect outcomes important to patients and physicians.
This scientific paper shows how healthcare organizations can estimate the financial benefits and potential ROI associated with implementing an AI platform in their radiology departments.
"As the uptake of AI-powered solutions continues to grow, decision-makers are progressively looking for tools that can assess the benefits of such investments in terms of time, cost, and revenue, as well as in reducing provider burnout and enhancing patient outcomes.
By scrutinizing the entire care continuum – from the ordering of a scan, through diagnosis and treatment decisions – this newly developed calculator empowers hospitals and health systems to fully comprehend the advantages of incorporating these AI-driven solutions into their workflows."
Prateek Bharadwaj
Global Market Access Manager Radiology
.jpeg?width=2000&height=2000&name=MicrosoftTeams-image%20(30).jpeg "MicrosoftTeams-image (30)")
"Healthcare providers are facing an ever-increasing volume of diagnostic imaging needs, and radiologists are struggling to keep up with the growing demand. Solutions that incorporate AI technology may ultimately help ease the workload, optimize the work output and improve patient care."
Dr. Lauren Nicola
CEO of Triad Radiology Associates and member of the Board of Chancellors at the American College of Radiology
-
Complete this form to access the paper
© 2024 Bayer
The descriptions, claims and visuals for all non-Bayer owned applications originate and are obtained from the application providers, or excerpted from publicly available information. Bayer is providing this content for your information, but does not own and control such content.
BAYER, the Bayer Cross and Calantic are trademarks owned by Bayer and/or registered in the U.S. and/or other countries. Other trademarks and company names mentioned herein are properties of their respective owners.
This is intended to provide information for healthcare professionals and other relevant decision makers in the United States, European Union, United Kingdom and Switzerland. Not all offerings are available in all markets. For availability specific to your country please contact your local Bayer representative. These materials are exclusively for professional use.
Calantic is ISO 27001 certified. The product Calantic Viewer has CE marking (CE2797). Complies with medical device legislation. Consult the operating instructions of a product for its intended use, characteristics and performance, contraindications, name of the manufacturer or its authorized representative and other essential information. The operating instructions of the product Calantic Viewer can be found on https://www.radiology.bayer.com/manuals
You are encouraged to report adverse events; reporting information can be found on https://www.bayer.com/en/pharma/report-side-effect
Any individuals depicted in this website are actors and not actual health care providers or patients. All patient data is fictitious. Images are an artistic representation for illustrative purposes only.